China’s Autonomous Agent, Manus, Changes Everything
By Craig S. Smith,
Forbes
| 03. 08. 2025
One recent evening in Shenzhen, a group of software engineers gathered in a dimly lit co-working space, furiously typing as they monitored the performance of a new AI system. The air was electric, thick with the hum of servers and the glow of high-resolution monitors. They were testing Manus, a revolutionary AI agent capable of independent thought and action. Within hours, its March 6 launch would send shockwaves through the global AI community, reigniting a debate that had simmered for decades: What happens when artificial intelligence stops asking for permission and starts making its own decisions?
Manus is not just another chatbot, nor is it merely an improved search engine dressed in futuristic branding. It is the world’s first fully autonomous AI agent, a system that doesn’t just assist humans — it replaces them. From analyzing financial transactions to screening job candidates, Manus navigates the digital world without oversight, making decisions with a speed and precision that even the most seasoned professionals struggle to match. In essence, it is a digital polymath trained to manage tasks across industries without...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...